Zomedica Corp. (NASDAQ:ZOM) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Zomedica Corp.

BRIEF

published on 12/04/2025 at 12:35, 17 hours 38 minutes ago

Zomedica Expands TRUFORMA Platform with Equine Progesterone Assay Launch

Zomedica Corp. Reproductive Health Progesterone Assay Equine Diagnostics Breeding Efficiency
PRESS RELEASE

published on 12/04/2025 at 12:30, 17 hours 43 minutes ago

Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Zomedica launches TRUFORMA Progesterone assay for equine reproductive health, expanding diagnostic platform. Market opportunity in equine reproduction with potential for improved breeding outcomes and cost savings

Zomedica Point-of-Care Diagnostics TRUFORMA Progesterone Assay Equine Reproduction Breeding Programs
BRIEF

published on 11/11/2025 at 12:35, 23 days 17 hours ago

Zomedica Plans Strategic Webinar for November

Investor Relations Animal Health Strategic Plans Zomedica Webinar Third-quarter Review
PRESS RELEASE

published on 11/11/2025 at 12:30, 23 days 17 hours ago

Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
Zomedica to host special webinar session providing strategic context for product platforms. Register for the November event at https://sholink.to/NovemberFriday

Diagnostic Solutions Webinar Zomedica Animal Health Strategic Context
BRIEF

published on 11/06/2025 at 12:35, 28 days 17 hours ago

Zomedica Secures ISO 13485 Certification for Operational Enhancement

Growth Strategy Operational Efficiency Quality Systems ISO 13485 Certification Global Market Readiness
PRESS RELEASE

published on 11/06/2025 at 12:30, 28 days 17 hours ago

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
Zomedica achieves ISO 13485 certification, bolstering quality systems, compliance, and global expansion strategy for animal health products

Certification Zomedica Global Market Animal Health ISO 13485
BRIEF

published on 11/04/2025 at 22:22, 1 month ago

Zomedica Reports Record Revenue Growth in Q3 2025

Diagnostic Products Q3 2025 Financials Zomedica Revenue Animal Health Growth Development Services
PRESS RELEASE

published on 11/04/2025 at 22:17, 1 month ago

Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success

Zomedica Corp. Diagnostics Therapeutic Devices Highest Revenue 19th Quarter Growth
BRIEF

published on 10/23/2025 at 12:35, 1 month 12 days ago

Zomedica Launches the Assisi Loop Lounge for Pet Therapy

Zomedica Animal Health Veterinary Innovation Assisi Loop Lounge TPEMF Therapy
PRESS RELEASE

published on 10/23/2025 at 12:30, 1 month 12 days ago

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Zomedica launches the Assisi Loop Lounge, a small animal tPEMF therapy bed offering full-body treatment and comfort, backed by peer-reviewed science and a lifetime warranty

Zomedica Veterinary Innovation Assisi Loop Lounge TPEMF Therapy Pet Comfort

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 38 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 43 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 13 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 8 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 13 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 43 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 22 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 48 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 58 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 3 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 13 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 28 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 29 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 12 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE